Nature Reviews Clinical Oncology, 1759-4782


More filtering options
  1. 2012
  2. The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

    Cornelissen, J. J., Gratwohl, A., Schlenk, R. F., Sierra, J., Bornhaeuser, M., Gunnar Juliusson, Racil, Z., Rowe, J. M., Russell, N., Mohty, M., Lowenberg, B., Socie, G., Niederwieser, D. & Ossenkoppele, G. J., 2012, In : Nature Reviews Clinical Oncology. 9, 10, p. 579-590

    Research output: Contribution to journalReview article

  3. 2010
  4. CHEMOTHERAPY Current drugs still have potential in advanced ovarian cancer

    Thomas Högberg, 2010, In : Nature Reviews Clinical Oncology. 7, 4, p. 191-193

    Research output: Contribution to journalDebate/Note/Editorial